Coverage

This Week at FDA: Pregnancy exposure registries, PRV fee rates, and more
The Reagan-Udall Foundation for the FDA and FDA are also co-hosting a hybrid meeting on 16 October to discuss where the patient voice is needed in the rare disease product development timeline, its impact, and opportunities for patients to engage in the…
Read More
Regan-Udall Foundation Report Provides Recommendations Related to Infant Formula Safety
The Reagan-Udall Foundation recently released a report summarizing lessons learned following investigations into 2025 and 2026 infant formula recalls due to the presence of Clostridium botulinum (C. botulinum).
Read More
IDFA Supports New Report Charting Path Forward on Infant Formula Safety
Reagan-Udall Foundation report provides a science-based roadmap for industry, government and researchers to better understand and address emerging C. botulinum spore in powdered infant formula risk.
Read More
Abbott Is Selling Sterility as a Feature. In Liquid Formula It Is Already the Rule
This month the Reagan-Udall Foundation published Applying the Science of Infant Formula Safety, a report on a July 13 roundtable convened with, and funded by, ByHeart and the International Dairy Foods Association.
Read More
Rischio di C. botulinum nelle infant formula
L’americana Reagan-Udall Foundation for the FDA (Fondazione) ha pubblicato un report che delinea una tabella di marcia basata su basi scientifiche per l’industria, i governi e i partner accademici al fine di affrontare il rischio di Clostridium…
Read More
Recommendations from Industry-Led Reagan-Udall Roundtable on Controlling C. botulinum in Infant Formula
Following two unprecedented infant botulism outbreaks linked to ByHeart- and Nara Organics-brand powdered infant formula in 2025–2026, a new report from the Reagan-Udall Foundation has outlined recommendations intended to advance scientific…
Read More
The ByHeart-funded report issues 22 recommendations without parents or mandates
A 44-page report prepared by the Reagan-Udall Foundation for the FDA has examined the presence of Clostridium botulinum in powdered infant formula after a July 2026 expert roundtable.
Read More
ByHeart and the Dairy Industry Paid for a Report on the Formula Botulism Outbreaks. It Has 22 Recommendations, No Parent in the Room, and No Rule
The Reagan-Udall Foundation for the FDA has published Applying the Science of Infant Formula Safety, a 44-page report on a July 13, 2026 roundtable about Clostridium botulinum in powdered infant formula.
Read More
IDFA Supports New Report Charting Path Forward on Infant Formula Safety
The International Dairy Foods Association (IDFA) today welcomed the release of a new report from the Reagan-Udall Foundation for the FDA (Foundation) outlining a science-based roadmap for industry, government and academic partners to address Clostridium…
Read More
FDA Seeks Public Input to Advance Development of Botanical Drug Products
The FDA announced a RFI to gather public input on opportunities to advance the development of botanical drug products.
Read More